Pursuant to the Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of the Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) ('Company') held today i.e. Wednesday, November 04, 2026

Date: 4th November, 2026 The Secretary, Listing Department Bombay Stock Exchange Ltd Phiroze Jeejeebhoy Towers, Street, Mumbai – 400 001 Reference: Scrip Code: 524723/ ISIN: INE491D01017 Subject: Outcome of Meeting of Board of Directors of Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) (“the Company”) in accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 (“Listing Regulation”) Respected Authorities, Pursuant to the Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of the Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) (“Company”) held today i.e. Wednesday, November 04, 2026 through video conferencing/other audio-visual has inter alia, considered and approved the following amongst other items of agenda: A. Proposed Rights Issue 1. Draft Letter of Offer In furtherance of the approval granted by the Board at its meeting held on 11th July 2026, the Board approved and adopted the Draft Letter of Offer ("DLOF") for the proposed Rights Issue of partly paid- up equity shares of the Company to the eligible equity shareholders, for an amount aggregating up to ₹21,000.00 lakhs (Rupees Two Hundred Ten Crore only), assuming full subscription, allotment and receipt of all call monies, pursuant to Section 62(1)(a) of the Companies Act, 2013 and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 ("SEBI ICDR Regulations"), for submission to BSE Limited, being the Designated Stock Exchange, for obtaining in-principle approval. The final terms of the Rights Issue, including the issue price, rights entitlement ratio, amount payable on application and on subsequent call(s), and the record date, shall be decided by the Rights Issue Committee / the Board, as applicable, and will be intimated to the Stock Exchange separately, in accordance with the SEBI Listing Regulations. This disclosure is made in terms of Regulation 30 read with Schedule III and other applicable provisions of the Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 as amended/updated from time to time and enclosed as “Annexure A”. B. Postal Ballot 1. The Board approved the conduct of a postal ballot, including remote e-voting, under Sections 108 and 110 of the Companies Act, 2013 read with the Companies (Management and Administration) Rules, 2014, for seeking the approval of the Members. 2. The Board approved the appointment of National Securities Depository Limited (NSDL) as the e- voting service provider for the postal ballot. 3. The Board approved the appointment of CS Chinmay Mohan Lele, Practising Company Secretary (Membership No. F-12351 / COP No. 28362), as the Scrutinizer for the postal ballot and e-voting process. The meeting of Board of Directors of the Company commenced at 4.10 p.m. and concluded at 6:00 p.m. The copy of the outcome is also being made available on the website of the Company at https://www.arvayahealth.com. We request you to take the above on record. Thanking you, Yours faithfully, For and on Behalf of Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) Kaushal Uttam Shah Managing Director DIN: 02175130 Place: Pune Date: 4th November 2026 Place: Pune Details with respect to Issuance of securities as required under Regulation 30 Read with Schedule III of the Listing Regulations and SEBI Circular HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026: Sr. No. Particulars Details 1. Type of securities proposed to be issued (viz. Equity Shares equity shares, convertibles etc.); 2. Type of issuance (further public offering, rights Rights Issue issue, (ADR/GDR), depository qualified receipts institutions placement, preferential allotment etc.); 3. Total number of securities proposed to be issued Amount not exceeding Rs. 210 Cr or the total amount for which the securities will (Rupees Two Hundred Ten Crore be issued (approximately); Only) 4. Any cancellation or termination of proposal for Not Applicable issuance of securities including reasons thereof.